ATG People in the News 8/1/15

Lynn Silipigni Connaway elected President-elect of ASIS&T

Lynn Silipigni Connaway

Lynn Silipigni Connaway

Lynn Silipigni Connaway, OCLC Senior Research Scientist, has been elected President-elect of the Association for Information Science and Technology (ASIS&T) for the 2016 administrative year, and President for 2017.
Connaway has been a member of ASIS&T for 25 years. She has served in a variety of leadership positions within the organization, including co-chair of the ASIS&T 2011 annual meeting and a Director on the Board from 2012-2015.
“I am honored to be elected to serve as ASIS&T President since the Association has been such an important part of my professional and academic career,” said Connaway. “I look forward to working with the Board and membership to continue to develop an association that attracts an international membership of students, researchers and professionals.”
ASIS&T President Sandy Hirsh, San Jose State University, noted that Connaway’s election “promises strong continuity of ASIS&T’s important strategic planning efforts, with thoughtful innovation and continued outreach.”
Becoming President-elect at the conclusion of the 2015 Annual Meeting in St. Louis, Missouri, Connaway will support 2016 President Nadia Caidi, University of Toronto, with planning and developing programs and structure. Connaway will have completed a three year term on the Board as Director at Large in November before becoming President-elect.

According to KnowledgeSpeak “Mary Ann Liebert, Inc., publishers has announced that Dr. Daniele Piomelli has been appointed Editor-in-Chief of Cannabis and Cannabinoid Research. Dr. Piomelli serves as Louise Turner Arnold Chair in Neurosciences and Professor of Anatomy and Neurobiology, Pharmacology, and Biological Chemistry at University of California, Irvine. He is also founding director of the unit of drug discovery and development (D3) at the Italian Institute of Technology in Genoa, Italy.

Dr. Piomelli is the author of more than 300 peer-reviewed articles, three full-length books, and 25 patents. He has received several awards and honours, including the Dargut and Milena Kemali Prize in Neuroscience and the National Alliance for Research on Depression and Schizophrenia (NARSAD) Outstanding Investigator Award.

He has made several contributions to the pharmacology of lipid-based signalling molecules. With his collaborators, he elucidated the biochemical pathways involved in the formation and deactivation of endocannabinoid substances – including anandamide and 2-AG – and uncovered various physiological functions served by these substances in the brain and in peripheral tissues. Additionally, his lab discovered the role of the lipid amides – oleoylethanolamide and palmitoylethanolamide – in the control of energy balance, inflammation, and pain, and identified their cellular receptors.

Cannabis and Cannabinoid Research claims to be the only peer-reviewed open access journal dedicated to the scientific, medical, and psychosocial exploration of clinical cannabis, cannabinoids, and the endocannabinoids system. The Journal publishes a broad range of human and animal studies including basic and translational research; clinical studies; behavioural, social, and epidemiological issues; and ethical, legal, and regulatory controversies.

Dr. Piomelli will take editorship immediately and begin developing the Journal to launch in Fall of 2015.

Pin It

Leave a Reply